The Central and Eastern Europe Fund, Inc. (NYSE:CEE), The European Equity Fund, Inc. (NYSE:EEA), and The New Germany Fund, Inc. (NYSE:GF) (each, a "Fund," and collectively, the "Funds") each announced today that its Board of Directors has approved an extension of the current repurchase authorization permitting open market share repurchase program for an additional twelve-month period. Each Fund may continue to purchase outstanding shares of its common stock in open-market transactions over the twelve-month period from August 1, 2024 through July 31, 2025 when the Fund's shares trade at a discount to net asset value ("NAV") and such purchases are deemed to be in the best interests of the Fun
The Central and Eastern Europe Fund, Inc. (NYSE:CEE) (the "Fund") announced today the results of its Annual Meeting of Stockholders which was initially called to order and adjourned on June 27, 2024 and reconvened on July 19, 2024. Both of the two Class III Directors nominated by the Board of Directors, Dr. Holger Hatje and Dr. Wolfgang Leoni, were elected at the reconvened meeting, to serve for a term of three years and until his respective successor is elected and qualifies. The Fund previously announced that, prior to the adjournment of the meeting on June 27, 2024, stockholders ratified the appointment of Ernst & Young LLP as the independent auditors for the Fund for its 2024 fiscal
The Central and Eastern Europe Fund, Inc. (NYSE:CEE) (the "Fund") announced today the results of its Annual Meeting of Stockholders held on June 27, 2024. Stockholders ratified the appointment of Ernst & Young LLP as the independent auditors for the Fund for its 2024 fiscal year. The nominees for election as directors of the Fund had not received sufficient votes to be elected. Therefore, the meeting was adjourned to July 19, 2024 at 2:00 p.m. at the offices of DWS Investment Management Americas, Inc., 875 Third Avenue, New York, NY in order to allow more time to solicit proxies. In addition, the Fund announced today that the Fund's investment advisor, DWS International GmbH, has volu
N-PX - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
N-CSRS - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
DEFA14A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
SC 13G/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
3 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. • InflaRx (NASDAQ:IFRX) is projected to report quarterly loss at $0.20 per share on revenue of $1.42 million. • Fennec Pharmaceuticals (NASDAQ:FENC) is likely to report quarterly loss at $0.02 per share on revenue of $8.67 million. • Welltower (NYSE:WELL) is likely to report quarterly earnings at $0.00 per share on revenue of $218.97 million. • VerifyMe (NASDAQ:VRME) is expected to report quarterly loss at $0.03 per share on revenue of $8.95 million. • Academy Sports (NASDAQ:ASO) is expected to report quarterly earnings at $2.2
Endeavour Mining (LSE: EDV) announced the abrupt termination of CEO Sébastien de Montessus, citing "serious misconduct" and irregularities linked to the sale of a company asset. Following the news, shares dropped by 14% before erasing some losses during the Friday session. Endeavour is a constituent of the FTSE 100 Index while also listed on the Toronto Stock Exchange. According to a statement, the London-based company took decisive action after uncovering an alleged “irregular payment instruction” amounting to $5.9 million related to an asset sale. Additionally, an external investigation into de Montessus’s conduct with colleagues, prompted by allegations from October, led to
Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million. • ImmunoPrecise Antibodies (NASDAQ:IPA) is projected to report quarterly loss at $0.17 per share on revenue of $3.96 million. • Blue Apron Hldgs (NYSE:APRN) is expected to report quarterly loss at $0.83 per share on revenue of $100.13 million. • Yiren Digital (NYSE:YRD) is estimated to report earnings for its second quarter. • KE Holdings (NYSE:BEKE) is likely to report quarterly earnings at $0.08 per share on revenue of $2.29 billion. • Hello Gr (NASDAQ:MOMO) is projected to report quarterly earnings at $0.29 per share on revenue
RBC Capital reiterated coverage of Centamin with a rating of Sector Perform and set a new price target of $115.00 from $128.00 previously
4/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)